Method and apparatus for monitoring the autonomic nervous system using non-stationary spectral analysis of heart rate and respiratory activity

• US 7,079,888 B2
• Filed: 03/12/2003
• Issued: 07/18/2006
• Est. Priority Date: 04/11/2002
• Status: Active Grant

• Current Assignee: Ansar, Inc., The Ansar Group Incorporated
• Original Assignee: Ansar, Inc.
• Inventors: Oung, Harry, Colombo, Joseph
• Primary Examiner(s): Getzow, Scott M.
• Application Number:
  US10/387,070
• Publication Number:
  US 20040111033A1
• Time in Patent Office: 1,224 Days
• Field of Search: 600508-523
• US Class Current: 600/513
• CPC Class Codes: A61B 5/02405 Determining heart rate variability
• CPC Class Codes: A61B 5/366 Detecting abnormal QRS complex, e.g. widening
• CPC Class Codes: A61B 5/4035 Evaluating the autonomic nervous system
• CPC Class Codes: A61B 5/726 using Wavelet transforms

Abstract

A method and apparatus for non-invasive, real-time monitoring of the autonomic nervous systems using non-stationary spectral analysis of both heart rate and respiratory signals. Continuous wavelet transformation is used in real-time so that the dynamic interactions between the sympathetic and parasympathetic divisions of the autonomic nervous system can be independently monitored in the frequency domain. The method in accordance with the present invention allows spectral analysis, formerly limited to the study of stationary data, to be applied to time-varying biological data such as heart rate variability and respiratory activity. In addition, the same techniques are used to monitor other biological or physiological data, including blood pressure.

Claims

1. A method for measuring activity of the autonomous nervous system of a patient comprising the steps of:

1) obtaining instantaneous heart rate signals of said patient;

2) computing a first power spectrum from said instantaneous heart rate signals using non-stationary signal analysis;

3) determining a level of sympathetic activity and parasympathetic activity from said power spectrum;

4) obtaining respiratory activity signals of said patient;

5) computing a second power spectrum from said respiratory signals using non-stationary signal analysis; and

,

6) determining the instantaneous respiration frequency from the said second power spectrum.

2. A method as set forth in claim 1, further comprising the steps of:

7) computing a low frequency area from said first power spectrum;

8) computing a respiration frequency area from said second power spectrum;

9)) using said low frequency area to determine a level of sympathetic activity;

10) using said respiration frequency area to determine a level of parasympathetic activity; and

11) using the ration of said low frequency area to said respiration frequency area to determining a level of sympathovagal balance.

3. A method as set forth in claim 2, wherein step 6.5 comprises:

11.1) comparing said ratio with a set of existing standards.

4. A method as set forth in claim 2, wherein step 2 and step 5 comprise computing said first power spectrum and said second power spectrum using analysis windows of four seconds or less.

5. A method as set forth in claim 4, wherein said level of sympathetic activity, said level of parasympathetic activity, and said sympathovagal balance are determined in a clinical setting using a test period of approximately 15 minutes and 35 seconds.

6. A method as set forth in claim 4, wherein said level of sympathetic activity, said level of parasympathetic activity, and said sympathovagal balance are determined in an operating room environment wherein patient monitoring is continuous.

7. A method as set forth in claim 4, wherein said level of sympathetic activity, said level of parasympathetic activity, and said sympathovagal balance are determined in a Neonatal Intensive Care Unit.

8. A method as set forth in claim 4, wherein said heart rate signals and said respiratory activity signals further comprise the steps of:

1.1) conducting a baseline test approximately 5 minutes in length to determine sympathetic level, parasympathetic level, and Sympathovagal Balance in a resting state;

1.2) conducting a relaxational deep breathing challenge approximately 1 minute in length to determine the reflex response of said parasympathetic level;

1.3) conducting a series of Valsalva maneuvers of approximately 15 seconds or less, wherein said series is approximately 1 minute and 35 seconds in length to determine the reflex response of said sympathetic level;

1.4) conducting a standing challenge approximately 5 minutes in length to determine said sympathetic level and said parasympathetic level in a orthostatic reflex.

9. A method as set forth in claim 8, further comprising the step of:

7) comparing the measurements of step 1.1 with the measurements of step 1.2, wherein the existence of overactive parasympathetic reflex is indicated when the respiratory frequency area measurement of step 1.2 is above the upper 85^th percentile of control/normal.

10. A method as set forth in claim 8, further comprising the step of:

8) comparing the measurements of step 1.1 with the measurements of step 1.3, wherein the existence of overactive sympathetic reflex is indicated when the low frequency area measurement of step 1.3 is above the 85^th percentile of control/normal.

11. A method as set forth in claim 8, further comprising the step of:

9) comparing the measurements of step 1.1 with the measurements of step 1.3, wherein the existence of Paradoxic Parasympathetics is indicated when the respiration frequency area measurements of step 1.3 is above the 85^th percentile of control/normal.

12. A method as set forth in claim 8, further comprising the step of:

10) comparing the measurements of step 1.1 with the measurements of step 1.4, wherein the existence of Paradoxic Parasympathetics is indicated when the respiration frequency area measurements of step 1.4 is above the upper 85^th percentile of control/normal.

13. A method as set forth in claim 8, further comprising the step of:

11). comparing the measurements of step 1.1 with the measurements of step 1.4, wherein the existence of Ortostatic Intolerance is indicated when the change in low frequency area measurements over the respiration frequency area measurements taken in step 1.4 is below the lower 15^th percentile of control/normal.

14. A method as set forth in claim 1, wherein said non-stationary signal analysis used in step 2 is continuous wavelet transforms.

15. A method as set forth in claim 1, wherein said non-stationary signal analysis used in step 5 is continuous wavelet transforms.

16. A method as set forth in claim 1, wherein step 1 is performed using a EKG.

17. A method as set forth in claim 1, wherein step 2 further comprises the steps of:

2.1) identifying ectopics within said heart rate signals; and

2.2) removing said ectopics from said heart rate signals.

18. A method as set forth in claim 1, wherein step 2 is performed using multi-rate filter banks.

19. A method as set forth in claim 18, wherein step 2 comprises the steps of:

2.3) down-sampling of said first power spectrum; and

2.4) poly-phase filtering of said first power spectrum.

20. A method as set forth in claim 1, further comprising the step of:

12) monitoring blood pressure of said patient.

21. A system for measuring activity of the autonomous nervous system of a patient comprising:

a first source providing instantaneous heart rate signals of said patient;

a signal processor coupled to said first source, said processor used to compute a first power spectrum of said heart rate signal using continuous wavelet transform techniques;

an output coupled to said signal processor, said output providing a visual display of said first power spectrum; and

a second source providing instantaneous respiration signals, wherein said signals are processed by said processor to obtain a second power spectrum, said second spectrum displayed on said output.

22. A system as set forth in claim 21, wherein said processor is a software program.

23. A system as set forth in claim 21, wherein said processors comprises programmable logic operating on distributed arithmetic hardware.

24. A system as set forth in claim 21, wherein said output comprises a video display screen.

25. A system as set forth in claim 21, further comprising a third source providing blood pressure data of said patient, said blood pressure data displayed on said output.

26. A system as set forth in claim 21, wherein said output displays the low frequency area, respiration frequency area, and the ratio of said low frequency area to said respiration frequency area as a continuous plot versus time.

27. A system as set forth in claim 21, wherein said output displays the low frequency area, respiration frequency area, and the ratio of said low frequency area to said respiration frequency area in digital format representing averages over periods of time.

28. A system as set forth in claim 21, wherein said output displays the low frequency area, respiration frequency area, and the ratio of said low frequency area to said respiration frequency area in three-dimensional analog form.